HC Wainwright & Co. Reiterates Buy on Calumet, Maintains $25 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Amit Dayal has reiterated a Buy rating for Calumet (NASDAQ:CLMT) and maintained a price target of $25.
October 07, 2024 | 9:35 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
HC Wainwright & Co. has reiterated its Buy rating for Calumet, maintaining a $25 price target, indicating confidence in the company's potential for growth.
The reiteration of a Buy rating and maintenance of a $25 price target by HC Wainwright & Co. suggests a positive outlook for Calumet, likely boosting investor confidence and potentially driving the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100